CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005225
NCT00005225N/ACompleted
CompareCT.gov

Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease

University of Utah·observational·Posted May 26, 2000·Updated Jan 21, 2016

In Brief

An observational study for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

To determine the relative risk in a defined population of angiographically demonstrated coronary artery disease due to genetic polymorphisms at the four apolipoprotein genomic regions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Coronary Arteriosclerosis, Coronary Disease
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
1988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartApr 1, 1988
Study CompletionMar 1, 1991
TodayJul 2, 2026
Posted 26.1 years ago